Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 7/2011

01-07-2011 | Research Articles

Long-term results and prognostic factors of patients with cervical carcinoma treated with concurrent chemoradiotherapy

Authors: Ana Reig, Ismael Membrive, Palmira Foro, Xavier Sanz, Núria Rodríguez, Joan Lozano, Martí Lacruz, Jaume Quera, Enric Fernández-Velilla, Manuel Algara

Published in: Clinical and Translational Oncology | Issue 7/2011

Login to get access
Metadata
Title
Long-term results and prognostic factors of patients with cervical carcinoma treated with concurrent chemoradiotherapy
Authors
Ana Reig
Ismael Membrive
Palmira Foro
Xavier Sanz
Núria Rodríguez
Joan Lozano
Martí Lacruz
Jaume Quera
Enric Fernández-Velilla
Manuel Algara
Publication date
01-07-2011
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 7/2011
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-011-0688-8

Other articles of this Issue 7/2011

Clinical and Translational Oncology 7/2011 Go to the issue

Educational Series / Red Series

Overview of preoperative radiochemotherapy in breast cancer: past or future?

Educational Series / Yellow Series

Is trastuzumab-induced cardiotoxicity involved in onco-cardiology outcome?

Research Articles

Twenty-year experience in the management of squamous cell anal canal carcinoma with interstitial brachytherapy

Research Articles

Maltose-binding protein isolated from Escherichia coli induces Toll-like receptor 2-mediated viability in U937 cells

Research Articles

Efficacy of taxanes as adjuvant treatment of breast cancer: a review and meta-analysis of randomised clinical trials

Research Articles

Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits